ESTRO GUIDE 2017

ESTRO/ESOR Multidisciplinary Approach of Cancer Imaging 2-3 November 2017 Rome, Italy

TARGET GROUP The course targets senior residents, junior radiologists and radiation oncologists who are interested to learn and improve their knowledge on an optimal approach tomultidisciplinary treatment management, exploiting the use of imaging. COURSE AIM This course, jointly organised by ESOR (European School of Radiology) and ESTRO, aims at promoting an integrated approach between specialists involved in multidisciplinary tumour boards to tailor the best treatment for each individual patient by exploiting the use of imaging. New advanced imaging technology not only provides morphological information on tumour extension, but also information on tumour function and biology. It not only allows a good evaluation of tumour response during and after treatment, but also an early detection of tumour recurrence. Radiation oncologists need to update their understanding of the possibility of modern imaging to optimise the multidisciplinary based clinical choices, to allow individualised radiation treatment prescrip- tion according to the tumour extension, response and movement. Radiologists involved inmultidisciplinary management teams increasingly recognise the impact of their diagnostic information and description on clinical decision-making and treatment planning. LEARNINGOUTCOMES By the end of this course participants should be able to: • Understand the role of imaging in tailoring an indi- vidualised risk based multimodality treatment by a multidisciplinary team • Identify themain relevant imaging features to optimise treatment modalities in: - upper abdomen - prostate cancer - rectal cancer • Exploit imaging in tailoring andmonitoring safe dose delivery.

COURSE CONTENT Imaging technology in radiology and radiotherapy: basic concepts • PET, MRI, radiation therapy technology. Liver tumours • Primary liver tumour and colorectal metastases im- aging evidences: anatomical, functional, monitoring, follow-up • What are the treatment options (surgery, RFA, TACE versus SIRT, stereotactic radiotherapy)? • What are the relevant imaging features that we need to know before, during and after the treatments? Imaging of liver tumours with modern CT and MRI • New MRI technology for imaging moving organs. Pancreatic tumours • Pancreas tumour imaging evidences: anatomical, • What is the relevant imaging features that we need to know before, during and after the treatments: state-of-the-art and future imaging • How can we adapt the treatment at the beginning and along the therapies by imaging? • Workshops liver and pancreas cancer. Prostate cancer • Prostate tumour imaging evidences: anatomical, functional, monitoring, follow-up • What is the pathway of tumour spread and what are the treatment options? • How accurate can imaging identify local tumour and nodal spread before, during and after the treatments? • How can we adapt the treatment at the beginning and along the therapies by imaging? • Workshops on prostate cancer. Rectal cancer, tumour extension at primary staging and at response evaluation • What are the pathways of tumour (nodal) spread and treatment options? • How accurate can imaging identify local tumour and nodal spread before, during and after the treatments (CT, MRI, Diffusion MRI, PET)? functional, monitoring, follow-up • What are the treatment options?

92

ESTRO SCHOOL